Bixiye
P35-17 Addition of Drug to the Substance Reduction Therapy Prior Authorization with Quantity Limit Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 13, 2017
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 3111 - 3120 ee natiijooyinka 3273
Bixiye
P34-17 Addition of Drug to the Amitiza (lubiprostone), Linzess (linaclotide), and Trulance (plecanatide) Prior Authorization Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 13, 2017
Bixiye
P33-17 Revised Reimbursement Policy for Anesthesia Services: Anesthesia
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2017
Bixiye
P32-17 Minnesota Senior Health Options Model of Care Requirements
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2017
Bixiye
QP13-17 Pharmacy Benefit Update - Evzio
Taariikhda wax ku ool ah ee barnaamijka: Jun 05, 2017
Bixiye
P30-17 New Drug-Related Prior Authorization (PA) Criteria: Topical Retinoids
Taariikhda wax ku ool ah ee barnaamijka: Jun 05, 2017
Bixiye
P29-17 New Drug-Related Prior Authorization (PA) Criteria: Erythropoietins
Taariikhda wax ku ool ah ee barnaamijka: Jun 05, 2017
Bixiye
P31-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Thrombopoietin Receptor Agents
Taariikhda wax ku ool ah ee barnaamijka: Jun 05, 2017
Bixiye
QP12-17 Prior Authorization/Pre-Approval Forms Specific to Select Medical Policies
Taariikhda uu dhaqangalayo Barnaamijka: May 31, 2017
Bixiye
2017 June Provider Press
Taariikhda uu dhaqangalayo Barnaamijka: May 30, 2017